Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
"Gastrointestinal homeostasis pathways" refers to the collective network of signaling, immune, metabolic, and neural processes that maintain the balance and normal function of the digestive tract[1][2][3][6]. These include the gut–brain axis, gut microbiota, endogenous peptide hormones (e.g., GLP-1, PYY), neural circuits (ENS), immune surveillance, epithelial barrier function, and nutrient-sensing systems[1][2][4][5][6]. Dysregulation can contribute to disease states including metabolic syndrome, diabetes, inflammatory bowel disease, and more[1][2][4][6]. However, as defined, the term is overly broad and not suitable for listing as a specific target for drug intervention; rather, it provides a conceptual framework for understanding the integrated regulation of GI health and disease.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gastrointestinal homeostasis pathways.